Inmunómica traslacional en neoplasias hematológicas
![Foto de Inmunómica traslacional en neoplasias hematológicas](/img/uploaded/3e36561c986d7b220271f71a9e0934d2.jpg)
![Foto de Southampton General Hospital](/img/noimage_org.png)
Southampton General Hospital
Southampton, Reino UnidoPublicaciones en colaboración con investigadores/as de Southampton General Hospital (2)
2022
-
Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics
European Journal of Haematology, Vol. 108, Núm. 1, pp. 73-83
2017
-
A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)
Leukemia, Vol. 31, Núm. 1, pp. 107-114